As of 2025-04-25, the Intrinsic Value of Talaris Therapeutics Inc (TALS) is -8.73 USD. This TALS valuation is based on the model Peter Lynch Fair Value. With the current market price of 2.72 USD, the upside of Talaris Therapeutics Inc is -421.08%.
Based on its market price of 2.72 USD and our intrinsic valuation, Talaris Therapeutics Inc (TALS) is overvalued by 421.08%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -8.73 - -8.73 | -8.73 | -421.08% |
| P/E | (23.09) - (36.09) | (25.15) | -1024.7% |
| DDM - Stable | (15.24) - (41.61) | (28.43) | -1145.1% |
| DDM - Multi | (0.24) - (0.49) | (0.32) | -111.9% |
| Market Cap (mil) | 116.44 |
| Beta | 0.01 |
| Outstanding shares (mil) | 42.81 |
| Enterprise Value (mil) | 98.09 |
| Market risk premium | 5.00% |
| Cost of Equity | 9.90% |
| Cost of Debt | 5.00% |
| WACC | 6.79% |